Pricing Log in Create free account

Niki BioSolutions, Inc. (NIKI) vs Xenetic Biosciences, Inc. (XBIO)

Niki BioSolutions, Inc. and Xenetic Biosciences, Inc. are both Biotechnology companies. Niki BioSolutions, Inc. and Xenetic Biosciences, Inc. are of similar size ($4.7M and $4.4M). Niki BioSolutions, Inc. grew revenue faster over the last twelve months: 42.6% against 33.3%. Xenetic Biosciences, Inc. has the higher net margin (−75.9% vs −921.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Niki BioSolutions, Inc. leads on 8 and Xenetic Biosciences, Inc. on 7.

Valuation

Metric NIKI XBIO Biotechnology median
P/E n/m n/m 10.60
P/S n/m 1.32 9.40
P/B n/m 0.71 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.40 0.66
EV/Sales 1.25 (0.32) 9.02
Earnings yield (418.75%) (64.48%) (32.88%)
Free cash flow yield 0.00% (53.86%) (23.13%)

Profitability

Metric NIKI XBIO Biotechnology median
Gross margin (87.96%) 100.00% 68.51%
Operating margin 0.00% (81.01%) 0.00%
Net margin (921.74%) (75.90%) 0.00%
Free cash flow margin 0.00% (70.93%) 0.00%
Return on equity 0.00% (47.05%) (51.96%)
Return on assets 0.00% (40.17%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NIKI XBIO Biotechnology median
Revenue growth (TTM) 42.64% 33.30% 6.76%
EPS growth (last fiscal year) 75.64% 38.52% 29.88%
Revenue growth, 5-year CAGR 2.38% 46.78% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NIKI XBIO Biotechnology median
Debt to equity 0.25 0.00 0.00
Current ratio 0.78 7.43 4.97
Net debt to EBITDA 0.02 2.78 1.01

Dividend

Metric NIKI XBIO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NIKI XBIO Biotechnology median
Market cap 4.68m 4.37m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack